Company news

Agilent Technologies, Inc. (NYSE:A) news

Agilent Technologies, Inc. news releases on 6ix. Latest, Oct 1, 2026: Agilent Introduces the NovoStation Sample Preparation System for Automated Flow…

Agilent Technologies, Inc. (NYSE:A) news

Press releases & updates

Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows

Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers

Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control

CORRECTING and REPLACING Agilent Announces Cash Dividend of 25.5 Cents per Share

Agilent to Participate in J.P. Morgan U.S. All Stars Conference

Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors

Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System

Agilent Introduces the Cary 635 FTIR Spectrometer

Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results

Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26

Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Agilent Increases Its Investment in HALO X-ray Technologies

Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma

Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis

Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight

Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies

Agilent Completes Acquisition of Biocare Medical

Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation

Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma

Agilent Introduces OpenLab Sync to Support Guided, Digital Execution in the Laboratory

Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results

Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control

Agilent Launches New GC Systems with GC Assist to Improve Laboratory Efficiency and Data Quality

Agilent Unveils the 9500 ICP-MS: Redefining Trace Element Analysis

Agilent Launches 1290 Infinity III Fluorescence Detector for Confident Trace Analysis at UHPLC Speed

Agilent and Singapore's NATi Partner to Advance Lipid-Conjugated Oligonucleotide Research

Agilent Names Michael Buckner as Chief Legal Officer

Agilent to Announce Second-Quarter Fiscal Year 2026 Financial Results on May 27

Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA®

Axion BioSystems and Agilent Technologies Resolve Litigation

Agilent Showcases Cancer Research Solutions at AACR 2026

Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma

MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer

Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026

Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States

Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions

Agilent Reports First-Quarter Fiscal Year 2026 Financial Results

Agilent to Participate in TD Cowen’s 46th Annual Health Care Conference

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)

Agilent Announces Cash Dividend of 25.5 Cents per Share

Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award

Agilent Showcases Next‑Generation Automated Solutions at SLAS2026

Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25

Agilent Accelerates Digital Pathology with the Launch of the Agilent S540MD Slide Scanner System

Wasatch BioLabs Announces Co-Marketing Agreement With Agilent to Advance Native-Read Targeted Sequencing

Agilent to Present at the 44th Annual J.P. Morgan Healthcare Conference

Agilent and Monash University Malaysia Mark 15-Year Partnership with New BioDiscovery Hub to Drive Regional Biotech Innovation

Agilent Announces 21 CFR Part 11 Compliance Software for xCELLigence RTCA eSight

Agilent Reports Fourth-Quarter Fiscal Year 2025 Financial Results